The firm’s wholly-owned subsidiary Dixon Display Technologies Pvt. Ltd. (DDTPL) will likely be transformed right into a three way partnership (JV), with Dixon holding 74% stake and HKC having the remaining 26% of the fairness.
Once the transaction is accomplished, Dixon Display Tech will function as a JV firm, combining its native presence with HKC’s worldwide experience to broaden superior show module manufacturing for India’s electronics and automotive sectors, the company said in an trade submitting.
The JV will concentrate on manufacturing, creating and distributing thin-film transistor LCDs, liquid crystal modules and different superior show modules for notebooks, cellphones, televisions, automotive shows, industrial functions and displays.
Dixon Tech stated the JV goals to strengthen India’s home electronics manufacturing, cut back dependence on imports and help the native part ecosystem beneath the “Make in India” initiative.
HKC’s funding required the Centre’s approval beneath Press Note 3 of 2020 and the Foreign Exchange Management (non-debt devices) Rules, 2019, due to cross-border funding laws.
Nomura sees 50% upside
Brokerage agency Nomura has a ‘purchase’ ranking on Dixon Tech with a value goal of ₹14,678 per share.
It stated the backward integration into show modules will drive structural margin tailwind.
Dixon Tech’s show plant building is already on observe with trials doubtless from the second quarter of the monetary yr 2027 and ramp up within the second half of FY27, Nomura stated.
Within elements, show module meeting (10% of invoice of fabric) has wholesome double-digit margins and 50 foundation factors to total margins for Dixon by FY28, the analyst projected, including as much as 100 foundation factors later, with full ramp up.
The inventory presently trades at 30 occasions its estimated earnings per share for FY28, it added.
JPMorgan ‘obese’ on Dixon Tech
Meanwhile, JPMorgan is ‘obese’ on the inventory however has reduce its goal value to ₹13,000 from its earlier ₹13,700.
It stated the JV approval will increase chance of getting the Vivo JV approval as properly.
It has estimated incremental EBITDA from the HKC JV into estimates, nonetheless reduce cell volumes attributable to continued headwinds from rising reminiscence costs. This drives 13-14% EPS cuts over FY27-28, the analyst estimated.
JPMorgan stated it stays ‘obese’ on Dixon Tech because it sees wholesome 36% earnings compound annual progress charge (CAGR) over FY26-28 on the again of elements foraying via Q Tech and HKC.
Dixon Tech shares had been up 6.1% at ₹10,399 apiece in early commerce on Tuesday. The inventory has declined 10.4% prior to now month.
Also Read: Reliance Industries shares offer valuation comfort, Morgan Stanley sees upside risks
